Prostate Cancer - Results from #1180

A global phase II randomized trial comparing oral taxane ModraDoc006/r to intravenous docetaxel in metastatic castration resistant prostate cancer. March 26, 2024

Three- and Seven-month Prostate-specific Antigen Levels as Prognostic Markers for Overall Survival in Metastatic Hormone-sensitive Prostate Cancer: Results from SWOG S1216, a Phase 3 Randomized Trial of Androgen Deprivation Plus Orteronel or Bicalutamide. March 26, 2024

Tissue-Based Genomic Testing in Prostate Cancer: 10-Year Analysis of National Trends on the Use of Prolaris, Decipher, ProMark, and Oncotype DX. March 26, 2024

RAPHIA: A deep learning pipeline for the registration of MRI and whole-mount histopathology images of the prostate. March 26, 2024

Ectopic JAK-STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance. March 26, 2024

Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin Dysregulation. March 26, 2024

Gender-Based Disparity Exists in the Surgical Experience of Female and Male Urology Residents March 25, 2024

The Transatlantic Recommendations for Prostate Gland Evaluation with Magnetic Resonance Imaging After Focal Therapy (TARGET): A Systematic Review and International Consensus Recommendations. March 25, 2024

The 2012 Briganti nomogram predicts disease progression in surgically treated intermediate-risk prostate cancer patients with favorable tumor grade group eventually associated with some adverse factors. March 25, 2024

Cognitive effects of long-term androgen deprivation therapy in older men with prostate cancer. March 25, 2024

TOward a comPrehensive supportive Care intervention for Older men with metastatic Prostate cancer (TOPCOP3): A pilot randomized controlled trial and process evaluation. March 25, 2024

Prostate Cancer Survivorship Essentials for men with prostate cancer on androgen deprivation therapy: protocol for a randomised controlled trial of a tele-based nurse-led survivorship care intervention (PCEssentials Hormone Therapy Study). March 25, 2024

Advanced Prostate Cancer: Treatment Advances and Future Directions. March 25, 2024

Clinical and genomic insights into circulating tumor DNA-based alterations across the spectrum of metastatic hormone-sensitive and castrate-resistant prostate cancer. March 25, 2024

Technical and biological constraints on ctDNA-based genotyping. March 25, 2024

SECuRE Update: First Participant Treated in the Last Cohort of Dose Escalation March 22, 2024

Other-cause mortality in incidental prostate cancer. March 22, 2024

A Compound that Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate Cancer. March 22, 2024

Incidence of complications and urinary incontinence following endoscopic enucleation of the prostate in men with a prostate volume of 80 ml and above: results from a multicenter, real-world experience of 2512 patients. March 22, 2024

High-intensity focused ultrasound with visually directed power adjustment for focal treatment of localized prostate cancer: systematic review and meta-analysis. March 22, 2024

Page 60 of 1436